Long intergenic non-protein coding RNA 1789 (LINC01789)

Long intergenic non-protein coding RNA 1789 (LINC01789) is a human long intergenic non-coding RNA (lincRNA), a subtype of long non-coding RNAs (lncRNAs) characterized by being longer than 200 nucleotides and not overlapping any protein-coding genes[1][3][5]. LINC01789, like other lincRNAs, is thought to play roles in gene regulation, chromatin remodeling, and transcriptional control, often with tissue-specific expression. While thousands of lincRNAs have been annotated, only a minority have been functionally characterized, and there is currently no evidence that LINC01789 is a direct therapeutic target, nor is there evidence of direct drug interactions or established disease roles[1][3]. lincRNAs may modulate physiological processes or fine-tune gene expression, but LINC01789's specific molecular and biological functions remain largely unstudied. Key details: - **It is not a receptor, enzyme, transporter, or canonical therapeutic target.** - **It is not associated with recognized interacting drugs, mechanisms of drug action, or clinical biomarkers.** - **No major safety or therapeutic challenges are reported, and its relevance in human disease is unknown.** Overall, LINC01789 is a well-defined genomic entity within the lincRNA category but is not a canonical drug target and has limited functional annotation in current literature[1][3][5].

Other names

LINC01789long intergenic non-coding RNA 1789